Skip to main content

Table 3 Linearities, LODs, LOQs, recoveries, and RSDs obtained by LC–MS/MS analysis method in Farfarae Flos

From: A LC–ESI–MS/MS analysis procedure coupled with solid phase extraction and MeOH extraction method for determination of pyrrolizidine alkaloids in Tussilago farfara and Lithospermi erythrorhzion

No.

Pyrrolizidine alkaloids

Range (ng/mL)

Linearity (r2)

LOD (μg/kg)

LOQ (μg/kg)

Recovery (%) mean ± SD, n = 3

Intra-day RSDb (%)

Inter-day RSD (%), n = 9

Low level

Medium level

High level

1

Echimidine

1.0–40

0.999

0.1

0.2

76.1 ± 2.8

78.8 ± 7.5

91.3 ± 3.5

18.8

11.6

2

Echimidine N-oxide

1.0–40

0.999

1.7

5.1

94.9 ± 1.6

97.6 ± 8.5

107.1 ± 1.8

0.9

2.7

3

Erucifoline

0.5–20

0.999

0.3

1.0

73.1 ± 5.9

78.1 ± 13.0

78.7 ± 4.2

12.0

7.4

4

Erucifoline N-oxide

0.5–20

0.999

0.2

0.6

84.4 ± 5.9

93.9 ± 12.3

89.8 ± 5.8

3.8

3.4

5

Europine

0.5–20

0.999

0.1

0.3

82.1 ± 3.7

77.8 ± 7.5

70.8 ± 5.1

8.6

7.5

6

Europine N-oxide

0.5–20

0.999

0.03

0.1

92.1 ± 2.5

84.9 ± 5.1

74.6 ± 11.6

7.2

7.7

7

Heliotrine

0.5 –20

0.999

0.03

0.1

88.7 ± 1.4

89.3 ± 8.3

91.7 ± 2.7

8.8

4.6

8

Heliotrine N-oxide

0.5–20

0.999

0.1

0.3

99.3 ± 1.7

99.4 ± 8.5

105.4 ± 2.9

5.1

4.8

9

Intermedine

0.5–20

0.999

0.1

0.2

82.3 ± 2.3

83.4 ± 10.0

84.5 ± 1.5

8.1

6.8

10

Intermedine N-oxide

0.5 –20

0.999

0.3

0.8

95.8 ± 1.6

93.5 ± 8.7

95.1 ± 3.8

1.6

1.0

11

Jacobine

2.0 –80

0.999

3.5

10.4

70.4 ± 3.0

73.1 ± 10.5

72.0 ± 3.5

10.6

12.9

12

Jacobine N-oxide

0.5–20

0.999

0.1

0.3

118.0 ± 1.6

117.5 ± 8.0

100.9 ± 15.6

3.5

4.6

13

Lasiocarpine

2.0–80

0.999

0.1

0.3

88.7 ± 2.4

92.6 ± 8.6

107.8 ± 4.5

14.3

10.0

14

Lasiocarpine N-oxide

2.0–80

0.997

8.1

24.2

108.9 ± 1.8

112.5 ± 9.7

117.0 ± 3.2

6.2

8.5

15

Lycopsamine

0.5–20

0.999

0.1

0.3

82.5 ± 2.1

83.0 ± 7.9

87.3 ± 0.8

14.3

6.2

16

Lycopsamine N-oxide

1.0–40

0.999

0.4

1.1

95.1 ± 3.1

98.8 ± 9.8

92.8 ± 4.3

12.4

7.0

17

Monocrotaline

0.5–20

0.999

0.3

0.8

88.0 ± 3.5

85.9 ± 9.2

92.6 ± 1.8

8.4

5.1

18

Monocrotaline N-oxide

0.5–20

0.999

0.2

0.6

101.0 ± 2.4

99.9 ± 10.3

100.0 ± 3.3

7.2

5.6

19

Retrorsine

1.0–40

0.999

3.1

9.3

79.8 ± 7.7

94.7 ± 11.1

81.0 ± 5.5

20.1

10.1

20

Retrorsine N-oxide

1.0–40

0.999

1.5

4.4

110.1 ± 3.5

103.2 ± 10.4

102.8 ± 3.6

3.8

6.6

21

Senecionine

2.0–200

0.999

a

106.6 ± 5.7

108.9 ± 4.7

111.2 ± 5.4

4.8

3.7

22

Senecionine N-oxide

2.0–200

0.999

113.1 ± 1.2

116.7 ± 3.9

119.0 ± 5.8

3.1

2.0

23

Seneciphylline

0.5–20

0.999

0.5

1.6

71.0 ± 3.6

76.1 ± 10.2

79.3 ± 6.9

17.6

6.5

24

Seneciphylline N-oxide

0.5–20

0.999

0.5

1.6

78.6 ± 6.3

86.2 ± 14.8

82.0 ± 2.1

16.9

6.3

25

Senecivernine

1.0–40

0.999

3.0

9.0

74.0 ± 2.8

81.6 ± 9.7

84.4 ± 7.8

17.8

7.2

26

Senecivernine N-oxide

1.0–40

0.999

0.8

2.3

95.3 ± 2.8

101.2 ± 10.0

112.3 ± 1.9

1.6

5.0

27

Senkirkine

2.0–200

0.999

92.8 ± 1.2

111.4 ± 12.8

114.3 ± 8.7

6.8

5.1

28

Trichodesmine

1.0–40

0.999

0.3

0.9

81.8 ± 2.1

87.0 ± 7.9

94.2 ± 2.8

8.0

2.5

  1. aNot available because saturation occurred by high content of the PA contained in the Farfarae Flos
  2. bRSD relative standard deviation